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Abstract
Colorectal cancer progresses through an accumulation of somatic mutations, some of which reside in so-called ‘‘driver’’
genes that provide a growth advantage to the tumor. To identify points of intersection between driver gene pathways, we
implemented a network analysis framework using protein interactions to predict likely connections – both precedented and
novel – between key driver genes in cancer. We applied the framework to find significant connections between two genes,
Apc and Cdkn1a (p21), known to be synergistic in tumorigenesis in mouse models. We then assessed the functional
coherence of the resulting Apc-Cdkn1a network by engineering in vivo single node perturbations of the network: mouse
models mutated individually at Apc (Apc
1638N+/2)o rCdkn1a (Cdkn1a
2/2), followed by measurements of protein and gene
expression changes in intestinal epithelial tissue. We hypothesized that if the predicted network is biologically coherent
(functional), then the predicted nodes should associate more specifically with dysregulated genes and proteins than
stochastically selected genes and proteins. The predicted Apc-Cdkn1a network was significantly perturbed at the mRNA-
level by both single gene knockouts, and the predictions were also strongly supported based on physical proximity and
mRNA coexpression of proteomic targets. These results support the functional coherence of the proposed Apc-Cdkn1a
network and also demonstrate how network-based predictions can be statistically tested using high-throughput biological
data.
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Introduction
The majority of nonhereditary colorectal tumors arise via the
sequential accumulation of mutations in key driver genes, where a
mutation in a tumor suppressor (e.g. Apc) or oncogene (e.g. Kras)
initiates the process, and a cascade of somatic mutations ensues
[1]. Although these mutations were classically thought to be
comprised of a few genes (e.g. Apc, Kras, Trp53), recent large-scale
sequencing efforts revealed that any given tumor includes (on
average) 80 mutations, with as many as 15 lying in frequently
mutated ‘‘driver’’ genes [2]. In support of the hypothesis that these
key genes function cooperatively in driving tumorigenesis, mouse
models mutated at two driver genes simultaneously have shown a
synergistic increase in tumor burden, including: Pten-Apc [3], Kras-
Tgfb [4], and Apc-Trp53 [5]. The evidence of synergistic, i.e. non-
additive, increases in tumor burden suggest that the signaling
pathways of two mutated genes may intersect downstream, and,
thus, predicting and interrogating these points of intersection – as
a biological network – is of significant interest. To trace the
connections between genes, a variety of high-throughput datasets –
e.g. protein-protein interactions (PPIs), gene coexpression, and
transcription factor relationships – have been employed to infer
functional associations that lend themselves to analysis as
networks, in which each gene or protein is represented as a node
and an interaction as an edge. Furthermore, network-based
analyses can be used to identify biomarkers [6], to predict tumor
progression [7], or to reveal the molecular alterations underlying
disease [8].
However, our current knowledge of biological networks is far
from complete. The coverage of current interactome databases is
estimated to be less than 10% of the total number of interactions
[9]. Thus, when interpolating the connections between driver
genes, network-based analyses that rely solely upon confirmed
interactions may lack essential connections. As one goal of our
research is to predict and analyze the functional paths between
driver genes, a critical step was to develop a predictive framework
to infer and evaluate novel connections between genes. The
framework proposed here (modeled on Pathfinder [10]) infers
missing edges using predictions from protein family relationships
and filters these paths based on known association rules. On the
other hand, since a cancer gene participates in multiple signaling
pathways, there may be dozens – if not, hundreds – of paths by
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approach is required to limit the network space to the specific
biological context of interest. To extract functionally relevant
subnetworks, the framework detects highly probable signaling
pathways based on gene-gene mRNA coexpression and Gene
Ontology [11] association rules mined from published pathways.
We used the computational method to elucidate the connections
between a well-known driver gene of intestinal cancer, Apc
(adenomatous polyposis coli), to another gene also involved in cancer,
Cdkn1a (previously known as p21). Though Cdkn1a was not found
to be mutated in populations of human colorectal cancers studied
to date [2], its expression level correlates with neoplastic
progression and has a prognostic value greater than that of
Trp53 [12]. Further supporting its importance in neoplasia, the
double mutant mouse, Apc
1638N+/2 Cdkn1a
2/2, exhibits a syner-
gistic increase in its tumor burden [13]. After predicting the
network linking Apc and Cdkn1a, we evaluated the relevance of
these predictions by manipulating the underlying system: gener-
ating in vivo network perturbations in two mouse models, followed
by systems-level ‘omic measurements from the small intestinal
epithelium. The ‘omic measurements – both proteomic and
genomic – of the perturbed system were used for the statistical
testing of the predicted network, thus introducing the concept of
evaluating in silico predictions against context-specific biological
data.
Materials and Methods
Network Analysis Framework
The network analysis framework (illustrated in Figure 1, and
explained in the Methods S1) employs the PathFinder architecture
outlined previously [10]. The raw network of publicly available
physical interactions is first pruned of false positives using a logistic
regression model that incorporates (i) the number of times a PPI is
observed, (ii) the Pearson correlation of expression measurements
for the corresponding genes, (iii) the proteins’ small world
clustering coefficient, and (iv) the protein subcellular localization
data of interacting partners. Positive (1000 PPIs from the
MIPS[14] database of interactions) and negative training data
sets (1000 randomly selected PPIs that are not in MIPS) are used
in 1000 cross-validation trials to acquire the parameters that
maximize the likelihood of a true interaction.
False negative interactions are inferred using sequence homol-
ogy relationships. It was observed that proteins with similar
sequences share similar interaction partners in the same organism
[15], and, thus, proteins from the same family are also likely to
have similar interaction patterns. The Pfam database, utiliz-
ing multiple sequence alignments and hidden Markov models
(HMMs), uses sequence similarity to formulate protein family
classifications [16] and serves as a useful tool for exploiting these
relationships. Hence, we inferred an interaction edge if (i) two
proteins do not interact with each other in the PPI network, and
(ii) there exists at least one interaction between the families of these
two proteins.
To identify those paths relevant to our model system of interest,
coexpression data based on microarray experiments from the
Apc
Min/+ mouse small intestinal epithelium were obtained from the
Gene Expression Omnibus (series GSE422 [17]); this study used
laser-capture microdissection to sample the crypts of adenomas,
carcinomas, and normal epithelium. In our implementation, we
used Pfam release 23.0 [16] and the Gene Ontology release in
August 2008 [11]. The search algorithm was extended to find
pathways up to 6 nodes in length, and the threshold for the
average coexpression of pathways was DrD~0:70.
Mouse Intestinal Epithelium Isolation
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the
Institutional Animal Care and Use Committee (IACUC) of Albert
Einstein College of Medicine (permit number 20070805).
Apc
1638N+/2 and Cdkn1a
2/2 C57BL6/J mice were generated as
described previously [13] and tissue samples were harvested using
the method outlined by Weiser et al., resulting in crypt and villus
populations of cells from the small intestine of Apc
1638N+/2,
Cdkn1a
2/2, and wild-type mice [18].
2D Differential In Gel Electrophoresis
2D Differential In Gel Electrophoresis (2D-DIGE) was per-
formed as previously described [19]. Differentially expressed
proteins from crypt and villus fractions were identified in the
mutant mice (Apc
1638N+/2 and Cdkn1a
2/2) relative to the respective
fractions from wild-type mice (4 replicates each). Univariate t-tests
(unequal variances and equal sample sizes) and multivariate linear
regression (coded in the R package LIMMA [20]) were performed.
Gel spots were selected for LC-MS/MS identification based on
these two t-statistics at the 0.05 level of significance.
Gel spots were excised, trypsin digested, and the peptides were
subsequently analyzed by tandem LC-MS/MS on a LC Packings/
Dionex Ultimate 3000 HPLC-Orbitrap XL (Finnigan, San Jose,
CA) system [19]. For interpretation of the MS/MS spectra, the
MASCOT software package was used to search the SwissProt
database; a null database of reversed peptide sequences was
searched simultaneously to account for false positives. Identified
proteins are listed in Table S1. Mascot DAT files have been made
publicly available through the Proteomics Identifications Database
[21], accession number 10638.
Gene Expression Profiling
Microarray studies for crypt and villus populations from
Apc
1638N+/2, Cdkn1a
2/2, and wild-type mice (4 replicates each)
were conducted on Affymetrix Mouse Genome 2.0 chips
according to published procedures [22]. All data is MIAME
compliant and the raw data have been made publicly available
through the MIAME compliant database, the Gene Expression
Omnibus [23], accession number GSE19338.
Network mRNA Analysis
Raw .CEL files were processed in MATLAB using the Robust
Multiarray Averaging procedure [24]. To deal with multiple
probes capturing different aspects of a gene product’s behavior, we
used all probes to represent a gene. Thus, in the following analysis,
each Apc-Cdkn1a network node, i, was represented by ki probes on
the array, resulting in a matrix of size q6n, where q~
P p
i~1
ki and
p~20. To determine whether the Apc-Cdkn1a network nodes were
collectively differentially expressed in a tissue compartment (crypts
or villi), we extended Hotelling’s T
2 statistic – a classical approach
useful for testing gene groups [25] – to incorporate multiple ex-
periments, as follows:
V2~   x xApc{  x xWT
  
S
{1=2
Apc S
{1=2
Cdkn1a   x xCdkn1a{  x xWT ðÞ
’
Where   x xG is the vector of mean mRNA intensity for all the q probes
for a genetic background, G, where G[ Apc,Cdkn1a,WT fg (Apc
indicating Apc
1638N+/2; Cdkn1a indicating Cdkn1a
2/2; and WT
indicating wild-type C57BL6/J). S is the absolute value of the
Testing Cancer Networks
PLoS ONE | www.plosone.org 2 September 2010 | Volume 5 | Issue 9 | e12497unbiased pooled sample covariance matrix for each mutant:
S~
1
nMutantznWT{2
X nMutant
i~1
xi,Mutant{  x xMutant ðÞ xi,Mutant{  x xMutant ðÞ
’z
         
X nWT
i~1
xi,WT{  x xWT ðÞ xi,WT{  x xWT ðÞ
’
         
Where Mutant can refer to either Apc
1638N+/2 or Cdkn1a
2/2, and the
absolute value in S is used to avoid imaginary components when
taking the inverse root of S in V2. It should be noted that probes
correspondingto Apc and Cdkn1a themselves wereexcluded, as these
areexpectedtohaveextremelylowintensityvalues(intherespective
mutants) that would skew the perceived aggregate network effect. In
V2, the difference of means,   x xMutant{  x xWT ðÞ , for each mutant may
be positive or negative for a probe i, so, unlike T
2, V
2 can be either
positive or negative.
Given that pwn, sample covariance estimates are not positive
definite, and hence, the inverse is singular. To circumvent this
issue, we set all covariances to zero for initial calculation of V
2 and
then calculate the significance of V
2 using a permutation test (i.e.
stochastically generating new ‘‘mutant’’ and ‘‘wild-type’’ phenotype
labels), thus preserving the underlying covariance structure in the
null distribution. Setting the off-diagonal elements of S to zero
simplifies V
2 to:
V2~StApc,tCdkn1aT
Thus, V
2 is simply the sum of the product of scaled t-statistics
calculated for each probe, in each of the two experimental
perturbations. As the number of samples was small (n~4 for
mutant and wild-type, each), random N 0,sq
  
noise was added to
each permutated matrix to obtain an interpolated and smoothed
empirical null distribution; the standard deviation, sq,G, of the
noise for each probe, q, in the genetic background, G, was
estimated by the sample standard deviation of each probe. 10000
such permutations were calculated to obtain the null distributions,
which –as expected – resemble F-distributions (see Figure S1).
Since Apc and Cdkn1a are both tumor suppressors and hypothe-
Figure 1. Framework for prediction of driver gene networks. The process begins with a two-step filtering process to account for false
positives and false negatives in interaction databases. After selecting the driver genes of interest, pathways are predicted and then pruned using
both GO term association rules and gene-gene coexpression values. Finally, the significant pathway segments are merged to arrive at a network
connecting the two driver genes. The framework incorporates tissue-specific mRNA coexpression at two levels: in the pairwise filtering of false
positives; and in the filtering of paths by average coexpression. The logistic regression model is trained on gold-standard interactome databases (see
Methods S1 for additional details).
doi:10.1371/journal.pone.0012497.g001
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expect the t-statistics to vary in the same direction if the null
hypothesis (of no joint effect) is to be rejected. Hence, we compute
the p-value of V
2 as the number of null observations greater than
our observed value of V
2. Calculating the p-value for the negative
tail of the distribution would be useful if the perturbations were
expected to have opposite molecular effects (e.g. Apc
+/2 paired
with a Stat3
+/2 hypomorph).
While we present an analysis for a 2-node perturbation of a
network, this analysis is extensible to k experimental perturbations
by computing pairwise V
2 statistics, resulting in a matrix:
V2 Matrix:
V2
11 V2
12 ... V2
1k
V2
21 P . .
.
. .
.
P . .
.
V2
k1 ... ... V2
kk
2
6 6 6 6 6 6 4
3
7 7 7 7 7 7 5
~
T2
11 V2
12 ... V2
1k
V2
21 P . .
.
. .
.
P . .
.
V2
k1 ... ... T2
kk
2
6 6 6 6 6 6 4
3
7 7 7 7 7 7 5
Where V2
jk represents the V2 statistic between perturbations j and
k; as shown, the diagonal reduces to a scaled version of Hotelling’s
T
2 statistic for each experiment. As the statistics are each of a
different scale, they cannot be compared directly, and, therefore,
the significance of each matrix element should be calculated (as
above) via a permutation test. Then, for the matrix of p-values, the
diagonal elements provide information about the significance of
individual experiments, while the off-diagonal values provide
information about pairwise experimental significance. The total
experimental support for network perturbations can then be
calculated by aggregating off-diagonal p-values, e.g. by Fisher’s
method [26]. We recommend this approach for dealing with k§3
perturbations; for k~2 perturbations, as in our case, the p-values
can be interpreted directly.
Analysis of Proteomic Targets
To assess the importance of physical proximity, the topological
distance between Apc-Cdkn1a network nodes and the respective
proteomic targets was calculated. Physical PPI networks were
assembled from BioGRID [27], the Human Protein Reference
Database (HPRD) [28], and IntAct [29]. Each network node was
tested independently for the number of 2-hop paths connecting it
to a set of n experimentally measured proteins, expressed as
follows:
Aj : aijajkw0, dik~1
gi~
X n
k~1
dik
Where aij is the entry at row i and column j in the adjacency
matrix, A, of the PPI network; i is a protein in the Apc-Cdkn1a
network; j is an intermediate protein; and k is an experimentally
measured protein. In this case, the experimental proteins were the
proteomic targets from either Apc
1638N+/2 or Cdkn1a
2/2 mice. If
there is at least one intermediate protein, j, for which a two-hop
path exists between nodes i and k, then the 2-hop distance, dik,i s1 ;
the total connectivity, gi, of protein i to the set of 2D-DIGE targets
is simply the sum of the dik. Significance was calculated against an
empirical null formulated from 10000 randomly generated sets of
proteins also of size n.
To assess patterns of coregulation, mRNA coexpression values
(Spearman’s correlation coefficient) were calculated from the
corresponding set of normalized microarray experiments, span-
ning wild-type, Apc
1638N+/2, and Cdkn1a
2/2 crypts and villi; the
probe with maximum intensity was used as the representative for a
gene. To test the significance of mRNA-level correlations, a
modified Kuiper’s test statistic, K, was calculated between the
group correlations (i.e. all probes on the array) and sample
correlations (i.e. set of 2D-DIGE targets) for each node in the
network independently; it is calculated as the sum of the maximal
and minimal deviations of the sample, FS, and control (i.e. entire
array), F, cumulative distribution functions [30]:
K~DzzD{~max FS{F ðÞ zmin FS{F ðÞ
As per the suggestions of Subramanian et al. [31], the Kuiper’s
statistic, K, was modified to improve its ability to detect bimodal
shifts in location of the sample distribution (as one would expect
coexpressed groups of proteins to show both positive and negative
correlations):
FS~PS rƒrx ðÞ ~
1
NS
X
yƒx
DryD where NS~
X
i[S
DriD
Where S is the set of proteins being tested (either the Apc
1638N+/2
or Cdkn1a
2/2 2D-DIGE targets); r is the ordered vector of
correlation coefficients between the respective 2D-DIGE targets
and a single network node; and NS normalizes FS to have sum 1.
Significance testing was performed using a normal approximation
of the empirical null: the empirical null was assembled from the
modified K calculated for 500 randomly selected protein sets, each
of size n~DSD, and maximum likelihood estimation was used to fit
a normal distribution. For exploring and illustrating the connec-
tions of significant (a=0.05) network nodes, we examine the subset
of correlations, ry, where yƒz such that Dz~PS rƒrz ðÞ {F and
FvPS rƒrz ðÞ ; and the subset of correlations, rp, where p§q such
that D{~F{PS rƒrq
  
and FwPS rƒrq
  
(analogous to the
‘‘leading edge’’ subset of GSEA [31]). To identify differentially
expressed nodes, we chose those nodes where the t-statistic
(unequal variance) of the maximum intensity probe was such that
DtiD§W{1 0:95 ðÞ in either the crypt or the villus compartment,
where W{1 is the normal inverse cumulative distribution function.
Testing each node in the Apc-Cdkn1a network independently
resulted in a p-value for each of the Ho,i null hypotheses, where i[n,
and each hypothesis, Ho,i, assumes that there is no relationship
(physically-based or coexpression-based) between the Apc-Cdkn1a
network node, i, and the 2D-DIGE targets. To test the group null
hypothesis that all Ho,i are simultaneously true, p-values were
aggregated into a statistic, t, suggested by Fisher; significance was
assessed against a x2 distribution with 2n degrees of freedom [26]
(see also Methods S1). The mutated node (Apc in Apc
1638N+/2 or
Cdkn1a in Cdkn1a
2/2) was excluded from the respective analyses, as
their extreme expression patterns skew the group-wise results.
Results
Driver Gene Network Predictions
The double mutant Apc
1638N+/2 Cdkn1a
2/2 mouse was
previously shown to exhibit a synergistic increase in its tumor
burden when compared with the single mutants [13]. To identify
the potential connections between Apc and Cdkn1a, we constructed
a predictive framework that, first, learns the annotation patterns
characteristic of known signaling pathways (e.g. those found in
KEGG [32] and others) and, then, couples these patterns with
tissue specific coexpression data to extract the most likely chains of
Testing Cancer Networks
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Figure 1). To identify only high-confidence pathways, a two-phase
filtering process was first applied to the global PPInetwork. In the first
phase, edges – compiled from mammalian interactions in BioGRID
[27] and HPRD [28] – were pruned from the network if they did not
resemblelikely interactions (as defined by a logistic regression model),
with the goal of reducing false positives among the reported
interactions. To account for false negatives (Phase 2), interactions
were added to the network by inferring relationships that are
precedented in model organisms based on protein family relation-
ships. After applying these measures to generate a synthetic network,
we searched for likely connections between Apc and Cdkn1a using both
gene coexpression data and Gene Ontology association rules.
To emphasize nodes and edges relevant to our biological
system, we introduced a tissue-specific bias in our search for Apc-
Cdkn1a connections by using gene expression data from the
intestinal epithelium of Apc
Min/+ mice. From these data, we
calculated the mRNA-level coexpression value for individual edges
via the gene-gene Pearson correlation coefficient. Next, all paths in
the synthetic network linking the gene products of Apc and Cdkn1a
were queried, and the predicted paths were filtered based on (i) the
support of association rules for GO annotations and (ii) the
average coexpression along a path; the result (at a significance level
of a=0.01) is shown in Figure 2. The Apc-Cdkn1a network includes
a number of previously known interactions (solid lines), as well as
predicted interactions (dashed lines) based on: (i) protein family
relationships, (ii) strength of GO association rules, and (iii)
microarray coexpression along the specific path connecting Apc
to Cdkn1a. As genetic interactions were included in the original
interaction databases, the predicted network includes both
physical and functional relationships.
At a systems-level, the proposed Apc-Cdkn1a network bears the
statistically unlikely property of being saturated with oncogenes: 8
of the 20 proteins are annotated as oncogenes in OMIM (p-
value,5610
210 by Fisher’s exact test, see Methods S1), and many
of the remaining genes have been experimentally shown to act as
oncogenes (e.g. Erbb3 [33,34], Shc1 [35], Map2k1 [36]). Although
the Apc-Cdkn1a network contains many well-studied proteins, the
node degree (i.e. number of interactions) within the subnetwork
does not strictly correlate with the node degree in the unfiltered
interaction database (Pearson’s correlation=0.51). For instance,
while AKT1 has many known interactions, its commonly studied
biological partners – namely, GSK3B and PTEN (both of which
are associated with Apc [3] and Cdkn1a [37] signaling) – do not
appear in the network. Other known interactions, such as that
between SHC1 and SRC [38], are also absent from the network.
Since our algorithm predicts connections biased by the biology of
the system under study (through the use of gene expression data
from Apc
Min/+ mouse intestinal tissue), a particular protein or edge
may not appear in the network if the pathway (i.e. chain of
proteins) on which it resides does not meet the gene coexpression
and/or GO association rule thresholds.
Conversely, the Apc-Cdkn1a network includes novel associations:
those not contained within the source databases (dashed edges in
Figure 2). Several of these interactions have recently been
validated in focused studies (see Table 1), providing confidence
that the framework is useful. In addition, the Apc-Cdkn1a network
also suggests that certain interactions previously associated with
other cancer models – such as the SRC-CCND1 functional
association found in prostate cancer [39], or the phosphorylation
of CDK4 by SRC in a cell line [40] – are relevant in this model of
colon cancer.
Figure 2. The Apc-Cdkn1a network. Solid edges represent previously known interactions; dashed edges represent predicted interactions; and
edges marked with a ‘‘v’’ represent predicted interactions that have been validated recently in the published literature.
doi:10.1371/journal.pone.0012497.g002
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As the Apc-Cdkn1a network represents the intersection of
signaling pathways emanating from Apc and from Cdkn1a,w e
expect to observe functional changes in network-associated proteins
in response to perturbations at either Apc or Cdkn1a. Single-node
perturbations were developed in mouse models with mutations in
either Apc (namely, Apc
1638N+/2)o rCdkn1a (Cdkn1a
2/2). While the
Apc-Cdkn1a network was generated using tumor-specific Apc
Min/+
data – a model harboring a number of background genetic lesions
[41] – the intestinal tissue obtained from the Apc
1638N+/2 and
Cdkn1a
2/2 mice at 3 months of age is relatively polyp free, thus
allowing us to gauge the effect of a single genetic perturbation on
the pre-neoplastic epithelium. Although this removes potential bias
that is introduced by subsequent mutations of neoplastic tissue, this
approach may also attenuate the flow of information between the
two genes.
Since we are using the two perturbations to determine how well
the Apc-Cdkn1a network can capture biological phenomena, we
introduced a multivariate statistic, V
2 to test if differences in mean
mRNA abundance exist jointly between the Apc
1638N+/2 and
Cdkn1a
2/2 models. By using V
2, as illustrated in Figure 3, genes
with mild differential expression in the two individual mutants can
contribute to the overall support of the network, as V
2 rewards
those genes where each of the two independent t-statistics are both
greater than 1. Statistical significance of V
2 was tested against a
permutation null, and, as our perturbations involved two tumor
suppressors expected to have molecular effects in the same
direction, we used the positive tail of the distribution. Knowing
that many molecules ‘‘switch’’ expression (i.e. high to low, or vice
versa) in the transition from crypts to villi [19], the microarray
datasets for these two biological compartments were tested
separately. We found that the Apc-Cdkn1a network was strongly
supported (p-value=0.002) by the joint mRNA differential
expression in the two mutants’ crypt compartment. Network
coherence was weaker (p-value=0.060) in the villus compartment,
and the network as a whole was not differentially expressed in the
villi of either mutant, noted in the two V
2 matrices’ p-values:
p{value V2
Crypt
  
~
Apc1638Nz={ Cdkn1a{={
Apc1638Nz={
Cdkn1a{={
0:871 0:002
0:002 0:009
  
p{value V2
Villus
  
~
Apc1638Nz={ Cdkn1a{={
Apc1638Nz={
Cdkn1a{={
0:645 0:060
0:060 0:247
  
Where, as mentioned, the diagonal elements indicate the signifi-
cance of differential expression within a mutant (as per Hotelling’s
T
2), and the off-diagonal elements indicate significance of joint
differential expression across mutants (as per V
2). In the crypts, the
network was differentially expressed in Cdkn1a
2/2 (p-value=0.009),
but not in Apc
1638N+/2 (p-value=0.871), and, yet, was jointly
supported by differential expression across both mouse models (p-
value=0.002). This illustrates that small mRNA-level changes that
are shared between multiple perturbations – on a gene-by-gene
basis – provide joint support for the network hypothesis, while any
individual perturbation may fail to demonstrate the claim.
To illustrate how the joint consideration of gene-wise behavior
operates, each network node has color-coded bubbles for the t-
statistics of both Apc
1638N+/2 and Cdkn1a
2/2 in Figure 3; the sum
is shown at the intersection of each gene’s bubbles. Though V
2
employs products of t-statistics, the sum is better suited for visually
demonstrating the principle that small mRNA effects can have a
significant impact when considered together. We observe that
several nodes that are differentially expressed in the crypts –
ERBB3, JAK2, MAPK8, et al. – are no longer differentially
expressed in the villus. In addition, some genes – e.g. CCNE1,
CAV2, FGFR1, EGFR – switch their direction of expression
between the crypts and villi.
Table 1. Published evidence validating interactions predicted in the Apc-Cdkn1a network.
Protein A Protein B Interaction Type System Description
MAPK8 CAV2
a Functional Human, fetal fibroblasts;
Human, lung tissue
CAV1 forms hetero-oligomers with CAV2, and CAV1 inhibits
TGF-beta or IL-6 induced phosphorylation of Mapk8 in
fibroblasts [51]
Functional Human, gingival fibroblasts siRNA knockdown of CAV1suppressed MAPK8 phosphorylation
[52]
SRC APC Functional Mouse, colon epithelial cell line Stable expression of SRC resulted in increased proliferation of
Apc
Min/+ cells versus Apc
+/+ cells [53]
SRC CCND1 Functional Human, breast cancer cell line SRC transfection leads to CCND1-CDK4-p27 complex formation
[54]
Functional Human, prostate cancer cell line SRC inhibition resulted in decreased binding of b-catenin to the
promoters of G1 phase cell cycle regulators cyclin D1 and c-Myc
[39]
Functional Mouse, renal cell line siRNA knockdown of SRC decreased CCND1 expression [55]
SRC CDK4 Phosphorylation Human, colon cancer cell line SRC phosphorylates CDK4 [40]
SRC PCNA Functional Human, ovarian cancer xenograft Administration of a small molecule inhibitor of SRC results in
decreased staining for PCNA in mouse carrying the xenograft
[56]
CDK4 CAV2
a Functional Mouse, ES cells Expression of CDK4 decreased upon knock-down of Caveolin-1
[57]
aThough CAV2 was discovered in the subnetwork, CAV1 and CAV2 are located adjacent to each other on chromosome 7 and express co-localizing proteins that form a
stable complex.
doi:10.1371/journal.pone.0012497.t001
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The 2D-DIGE analysis reported 12 proteins differentially
expressed for the Cdkn1a
2/2 intestinal epithelium (crypts and villi
combined) versus wild type, and 31 proteins differentially
expressed in the epithelium of the Apc
1638N+/2 mice versus wild
type (Table S1). To test our network-based hypothesis, we first
assumed that the set of regulatory molecules in the Apc-Cdkn1a
network are independent. Then, the one and two-hop physical
interactions were assessed for each network node (see Figure 4).
While directly interacting neighbors (one hop) are typically useful
in mapping signaling pathways, they did not associate much of the
proteomic data with the network. Also, the few direct connections
were not statistically significant; EGFR, for example, tends to have
many interactions, and, thus, EGFR’s direct connections to the
2D-DIGE targets were not more likely than expected by chance.
However, analysis of indirect interactions (two hops) from network
Figure 3. Differential expression of the Apc-Cdkn1a network in villi (top) and crypts (bottom) for the Apc
1638N+/2 and Cdkn1a
2/2
mouse models. Each network gene is represented by two overlapping bubbles colored according to the t-statistics (unequal variance) in the two
mutants: the lower left bubble of a gene corresponds to the t-statistic for Apc
1638N+/2, and the upper left bubble to the t-statistic for Cdkn1a
2/2. The
intersection of the two bubbles corresponds to the sum of the t-statistics, illustrating how the significance of small effects can be strengthened when
considered jointly. Nodes downregulated in the mutant are colored pink, those upregulated in the mutant are yellow, and neutral t-statistics are grey.
While V
2 is calculated using all probes for each gene, we use only the probe with maximum intensity to calculate the t-statistics for visualization.
doi:10.1371/journal.pone.0012497.g003
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targets (individual node’s p-value ,0.005), as illustrated in
Figure 4B. Considering the network as a whole and aggregating
the p-values (aggregate statistic, t), the network was significantly (p-
value of t,1610
215) physically associated with either the
Apc
1638N+/2 or Cdkn1a
2/2 2D-DIGE targets, suggesting that the
proteome-level effects are at most 4-hops away from the causative
mutations.
Based on the physical proximity of the 2D-DIGE targets to the
Apc-Cdkn1a network, we hypothesized that these network proteins
might be controlling the expression of the 2D-DIGE targets. To
examine this relationship further, we studied the pattern of
mRNA-level coexpression between network nodes and the 2D-
DIGE targets. As before, the network nodes were assumed to be
independent, and the pattern of coexpression was assessed for each
node individually using a modified Kuiper’s test statistic, K; nodes
identified as (i) being differentially expressed (DtiD§W{1 0:95 ðÞ )i n
either crypts or villi and (ii) having significant (a=0.05)
coexpression with the 2D-DIGE targets are highlighted in
Figure 5. Fifteen nodes in the Apc-Cdkn1a network had significant
mRNA-level correlations to the Apc
1638N+/2 2D-DIGE targets,
and four of these were also differentially expressed. On the other
hand, eight nodes had significant correlations to the Cdkn1a
2/2
2D-DIGE targets, and four of these were individually differentially
expressed. Considering coexpression relationships from theApc-
Cdkn1a network as a whole, the p-value of t for coexpression
between Apc-Cdkn1a network nodes and Apc
1638N+/2 2D-DIGE
targets was strongly significant (all nodes excluding Apc and
Cdkn1a, p-value,1610
220; differentially expressed nodes, p-
value=1.4610
25). Given the magnitude of these group-wise
statistics, however, the evidence for Apc-Cdkn1a network coexpres-
sion with the Cdkn1a
2/2 2D-DIGE targets was not as well-
supported (all nodes, p-value of t=3.1610
28; differentially
expressed nodes, p-value of t=1.6610
23). Given that t can be
influenced by a few small p-values, we also calculated the
probability of observing kp -values less than a=0.05, which, as a
binomial distribution, is more sensitive to larger p-values. This also
indicated that the Cdkn1a
2/2 2D-DIGE targets were least
supported by coexpression with the Apc-Cdkn1a network, with
the p-values separated by two orders of magnitude again (p-value
Figure 4. Physical connections between the 2D-DIGE targets and the Apc-Cdkn1a network. (A) Direct physical linkages between 2D-DIGE
targets and network nodes. (B) Indirect (2-hop) physical linkages between 2D-DIGE targets and network nodes. Node size corresponds to the number
of 2-hop interactions it possesses. Apc
1638N+/2 2D-DIGE targets marked with a ‘‘*’’ were also found in the Cdkn1a
2/2 intestinal epithelium.
doi:10.1371/journal.pone.0012497.g004
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2/2 targets with differentially expressed
network nodes was 3.3610
25; p-value for coexpression of
Apc
1638N+/2 targets was 3.1610
27).
Finally, knowing that the use of a single probe per gene is often
misleading, the above calculations for proteomic coexpression
were also performed using all microarray probes for the network
nodes and the proteomic targets. By this approach, the network
as a whole was strongly coexpressed in either mutant (for
differentially expressed probes, excluding those belonging to
Apc or Cdkn1a, p-value of t,1610
220). However, for ease of
interpretability and visualization, we discuss the results of the
analysis using only the maximum intensity probe per gene.
Discussion
As underscored by Wood et al. [2], colorectal cancer is the
product of mutations in multiple genes operating simultaneously.
Though tumors differ at the genetic level, their phenotypes
intersect at histopathologic levels and, in our view, at the
molecular level, as well, implying that the connections between
unique sets of mutations may often merge at downstream
signalling hubs. Thus, the reduction of genetic heterogeneity into
clinically meaningful biological networks could have an impact in
the context of personalized medicine. As a step towards this goal,
we developed a computational framework capable of predicting
functional connections between genes mutated in cancer, and we
applied our methodology to define a network between Apc and
Cdkn1a.
Networks, as abstractions of underlying molecular phenomena,
offer the hope of distilling system-level structure from biological
complexity. Given the many degrees of freedom in the underlying
datasets (PPIs, microarrays, et al.), however, numerous network
structures are possible for a particular biological context, and
candidate networks are often evaluated solely based on topological
significance (e.g. the G-score of MetaCore [42]). Yet, the value of a
network may not be reflected topologically; for example, a highly-
connected hub may not be highly active in a particular model
system. If a network model truly reflects the underlying biology,
Figure 5. Coexpression between the 2D-DIGE targets and the differentially expressed Apc-Cdkn1a network nodes. To examine the
network-based hypothesis, each network node was tested independently for significant correlation with the Apc
1638N+/2 or Cdkn1a
2/2 2D-DIGE
targets using a modified Kuiper’s test statistic. The 2D-DIGE targets are ordered by the amount of second-degree physical interaction, per Figure 4;
node size is proportional to the number of coexpression interactions with differentially expressed signaling proteins. Apc
1638N+/2 2D-DIGE targets
marked with a ‘‘*’’ were also found in the Cdkn1a
2/2 intestinal epithelium.
doi:10.1371/journal.pone.0012497.g005
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underlying system should be manifest in and around the predicted
network. Specifically, since a network connecting two cancer genes
represents cross-connections between signaling pathways, one
would expect that perturbations along a pathway would result in
altered regulation of network-associated nodes.
A systems-based approach required to biologically evaluate
network coherence, however, is not immediately amenable to the
tools of classical molecular biology, which are designed to target
single molecules or, at most, a few at a time. As an alternative, we
outline the use of in vivo single node perturbations – by way of
mouse models with targeted inactivation of specific loci – followed
by gene and protein expression analysis to gauge systems-level
effects. For further investigation, numerous mouse models for
cancer biology are already available, and these resources can be
productively mined to expand our understanding of cancer gene
networks. Though we have demonstrated the value of biologically
testing network predictions using 2D-DIGE and microarray data,
many other types of screening tools could also be employed to test
the functional coherence of predicted networks.
Due to the differences in coverage of proteomic and gene
expression data, different approaches were required to probe the
potential functional coherence of the network: V
2 – a multivariate
statistic – was used to gauge the effect of single node perturbations
on mRNA-levels of the Apc-Cdkn1a network, while, due to reduced
coverage, relational maps – physical and coexpression – were
required to assess the effect of driver gene mutations on the
proteome. We found that the Apc-Cdkn1a network was supported
by the joint differential expression of mRNA in two different
network perturbations, with stronger differential expression being
observed in the crypts (Figure 3). The V
2 statistic is presented in a
framework that is extendable to multiple network perturbations –
a feature that proves necessary in evaluating the biological
coherence of networks, as small mRNA-level effects of an
individual perturbation may fail to lend adequate support for a
predicted network; coupling multiple perturbations together via
the V
2 matrix allows the integrity of the network to be assessed via
a biologically multidimensional approach. It should be noted that,
in testing the mRNA-level support for an individual network, a
‘‘self-contained’’ hypothesis is necessary, embodied by null
distributions – such as the permutation null used here – modeling
the population from which the samples (mice) were drawn; gene
randomization methods, on the other hand, compare network
expression patterns to stochastically chosen gene groups, which are
bound to have a different and/or reduced covariance structure
(especially without incorporating network structure to generate the
null gene sets), leading to overinflated significance values [43].
After applying V
2 to the mRNA data, we found that the network
was better able to capture joint differential expression in the crypts
than in the villi, suggesting that oncogenic transformations are
initiated in the crypts by the network genes and then transduced to
downstream targets in the villi. This is reflected in Figure 3, where
the t-statistic of individual nodes is colored for both mouse models,
and more nodes are seen to be brightly colored (i.e. highly
differentially expressed) in the crypts. Interestingly, a large
contingent of oncogenes – ERBB3, JAK2, MAP2K1, MAPK8 –
are clearly downregulated in the crypts, while their expression
levels diminish considerably in the villi, indicating that these genes
turn ‘‘off’’ during the crypt-to-villus transition – a well-known
feature of this biological compartment [19]. Though the down-
regulation of oncogenes may appear counterintuitive, it is to be
expected in these particular mouse models, where the tumorigenic
phenotype is mild and the tissue has been harvested in the pre-
neoplastic regime. Before the onset of tumors, the downregulation
of oncogenes represents a homeostatic reflex of the tissue to the
genetic perturbations, i.e. protective downregulation of oncogenes
to compensate for the loss of Cdkn1a or Apc. In addition to genes
turning ‘‘off’’ in the crypt-to-villus transition, several genes appear
to switch their pattern of expression entirely. In particular, CDK3,
CAV2, EGFR, and FGFR1 exhibit this behavior, which suggests
that they play two different roles in the two compartments.
For visualization, we show only the probe with maximum
intensity across all samples for each gene. Given the extent of
alternative splicing and array manufacturing variation, however, a
single probe can be misleading. Hence, for calculation of statistical
significance, we use all probes to model a single gene – a more
robust approach that is amenable to matrix-based calculations
(such as V
2). We concede that, since each gene is represented by a
different number of probes, genes with many probes contribute
proportionally more weight to the final V
2 statistic. This is a useful
feature, however, as we have more confidence about the true
behavior of these well-probed genes – many of which are well-
studied and important in cancer, such as Egfr (7 probes) and Mapk8
(5 probes) – and, thus, they deserve greater weight than the highly
variable, single-probe genes.
Proteomic data, however, requires different analytical consid-
erations, as the protein levels of the network nodes may not be
directly measured in a given proteomic experiment. To make
inferences about our network-based hypothesis, we used two
different mappings: one based on physical interactions, and
another based on mRNA correlations. From Figure 4, it is clear
that the proteins measured in the 2D-DIGE experiment are not
merely a random sampling from the proteome. Rather, they are
physically close to (i) the hypothesized network as a whole (p-value
of t,1610
215) and (ii) several individual signaling molecules
(individual p-values,0.005). Specifically, the 2D-DIGE targets
from the Apc
1638N+/2 and Cdkn1a
2/2 experiments have significant
physical proximity to CTNNB1, FGFR1, ERBB3, CAV2, and
CDKN1A itself. The tight physical proximity of the predicted
network nodes to experimentally measured targets suggested that
the signaling molecules more proximal to the mutations may
regulate the proteomic targets, and we used mRNA-level
coexpression to examine this relationship further. While coexpres-
sion relationships abound between the Apc
1638N+/2 2D-DIGE
targets and the Apc-Cdkn1a network nodes, this is less significant for
the Cdkn1a
2/2 targets (p-value of t=3.3610
23). Taken together
with the results of the mRNA analysis, this suggests that the
hypothesized network nodes more effectively capture Cdkn1a
2/2
signaling at the mRNA level rather than at a proteomic level,
whereas the opposite is true of Apc signaling.
While the network as a whole showed differences in the level of
proteomic coexpression, two differentially expressed nodes –
MAP2K1 and AKT1 – were significantly coexpressed with the
measured proteome in both network perturbations (Figure 5).
Interestingly, AKT1 was also found to be closely physically
associated with the proteomic targets in Cdkn1a
2/2, while
MAP2K1 was physically associated with Apc
1638N+/2 2D-DIGE
targets (Figure 4). As we know that mRNA coexpression can
provide evidence regarding the regulatory role of proteins [44], the
mutual discovery of MAP2K1 and AKT1 in the two network
perturbations – via both coexpression and physical connectivity to
the perturbed proteome – suggests that these two proteins may
serve as intersection points of Apc and Cdkn1a signaling. Also of
interest is the observation that coexpression connections and
physical connections tend to associate different subsets of the
proteomic targets, as the more physically distant proteomic targets
(e.g. SULT1B1, OTC, KRT19) are also the ones that tend to be
coexpressed with multiple network nodes. Not only does this
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dimensions of biological function, but it also illustrates the
necessity of using both maps to provide complementary informa-
tion in evaluating the molecular context of network hypotheses.
While the 2D-DIGE studies revealed many differentially
expressed proteins, annexin A2 (ANXA2) was among the most
highly ranked in its physical proximity to the hypothesized
network. At the protein level, ANXA2 was upregulated in both
mouse models of colon cancer (see Table S1). From studies of
prostate cancer [45], ANXA2 upregulation is expected since in vitro
experiments indicate that overexpression promotes a more
invasive, proliferative cell phenotype. Though ANXA2 had high
mRNA expression in one population of human colorectal tumors
[46], it is downregulated in some populations of human prostate
tumors [45] and colorectal cancer cell lines [47]. Since activation
of either Apc or Cdkn1a signaling leads to upregulation of ANXA2
in our studies, activation of alternative or repressive pathways may
lead to such unexpected downregulation of ANXA2 in some
tumors.
In addition to ANXA2, the mutant mice exhibited other
protein-level alterations that can potentially contribute to
tumorigenesis. Elongation factor E2 (EEF2), for example, was
found to be upregulated in both mouse models, and its
tumorigenic potential in gastrointestinal [48] and breast [49]
cancers is well known. Though drugs inhibiting the EEF2 pathway
(via its kinase) exist [50], and molecular chemotherapy targeting
ANXA2 can also be envisioned, our network-based hypothesis
suggests these changes may be controlled by specific upstream
signaling molecules that integrate the information from mutated
genes. Thus, in patients where levels of ANXA2 or EEF2 are
elevated, molecular therapy targeting the proposed upstream
network targets – such as MAP2K1 or AKT1 – may be more
effective.
In conclusion, we outline a novel method for identifying
networks that connect signaling pathways associated with cancer
driver genes. The first step towards statistically analyzing these
novel subnetworks was pursued using single node perturbations of
the system in vivo, followed by network interrogation via high-
throughput -omics experiments. Together, the various lines of
evidence – mRNA differential expression, 2D-DIGE-target
physical proximity, and 2D-DIGE-target coexpression – strength-
en the hypothesis that the Apc-Cdkn1a network helps to mediate
both Apc and Cdkn1a signaling. Thus, we show that using ‘omic
data to test a network-based hypothesis not only allows one to
assess the biological validity of in silico predictions, it also allows
one to prune the hypothesis to identify molecular targets (e.g. SRC
and EGFR) that are likely to integrate the various signaling
pathways perturbed in cancer.
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